FindTrial
Sign In

Construction of tumor evolution database based on multi-drug resistant tumor live database and PDTX model

Construction of tumor evolution database based on multi-drug resistant tumor live database and PDTX model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074148
Enrollment
Unknown
Registered
2023-07-31
Start date
2023-07-21
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor

Interventions

Case series:NA

Sponsors

Changzhou NO.2 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All samples in this project were derived from tumor tissue, thoracoabdominal fluid, blood samples and wax blocks/rolls of patients with multi-drug resistant tumors who met clinical examination criteria. The collection criteria for each sample are Tumor tissue samples are not less than 1cm3 each time. Para-cancer tissue samples are not less than 1cm3 each time. About 800ml of thoracoabdominal water. The blood sample was 10ml/tube. Wax block/roll: FFPE wax block or roll (10-15 tablets) within 2 years before individual medication.

Exclusion criteria

Exclusion criteria: Improper sampling of tissue and blood samples resulting in necrosis or contamination.

Design outcomes

Primary

MeasureTime frame
Genomics;Histopathology;—

Countries

China

Contacts

Public ContactHua Jiang

Changzhou NO.2 People‘s hospital

czeyjh@njmu.edu.cn+86 180 1585 2711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026